U.S. Household Products Stock News

NYSE:HCI
NYSE:HCIInsurance

HCI Group (HCI) Stock May Be Reasonable Following Record Q2 Results

HCI Group stock has more than tripled over the past three years while the broader valuation checks still flag it as looking cheap. This raises a clear question about how much good news is already in the price. HCI Group has delivered a very large 237.0% return over the past three years, which puts recent short term moves into context for anyone thinking about new capital going into the stock. Strong recent earnings and the completed US$80 million share repurchase program can support...
NYSE:ICL
NYSE:ICLChemicals

Why Did ICL Group (ICL) Move Today?

ICL Group (NYSE:ICL) is back in focus after reporting second quarter 2026 sales of US$2,135 million and net income of US$137 million, alongside board approval for a new end market operating model. See our latest analysis for ICL Group. The recent earnings update and operating model shift have come alongside a 9.90% 30 day share price return, yet ICL Group’s share price is still down 13.55% over 90 days and its 1 year total shareholder return is down 7.98%. This suggests improving short term...
NYSE:CSW
NYSE:CSWBuilding

2% Overvalued? CSW Industrials (CSW) Looks Fully Valued Following Its Recent Run

CSW Industrials (CSW) has drawn investor attention after its recent share price move, with the stock closing at $345.15. This follows strong multi year total returns and positive annual revenue and net income growth. See our latest analysis for CSW Industrials. Over the past year CSW Industrials has combined a 16.99% year to date share price return with a 33.51% total shareholder return. Its 30 day and 90 day share price returns of 23.59% and 32.65% suggest momentum has recently...
NYSE:FHN
NYSE:FHNBanks

How Investors Are Reacting To First Horizon (FHN) Earnings Beat And Loan Growth Momentum

In early August 2026, First Horizon Bank promoted veteran Baton Rouge banker Michael Doerr to Senior Vice President, Senior Commercial Banking Sales Manager, while parent company First Horizon National reported second-quarter earnings per share of US$0.54, ahead of expectations on the back of higher net interest and non-interest income and growth in loans and deposits. Alongside this leadership move, the bank’s improved credit quality, share repurchases of US$100 million, and constructive...
NasdaqGM:QCRH
NasdaqGM:QCRHBanks

QCR Holdings (QCRH) Keeps Fair Value In Focus Following Its Strong Stock Run

Recent performance and what it might mean for QCR Holdings QCR Holdings (QCRH) has attracted attention after a strong run in its stock price over the past year, with total return figures that stand out against its recent history. Over the past month the stock returned about 8%, while the past 3 months show a return of roughly 20%. Year to date, QCR Holdings has delivered a total return of about 30% and the 1 year total return is around 43%. Looking further back, the 3 year total return is a...
NYSE:PRI
NYSE:PRIInsurance

Will Stronger Q2 Earnings and Capital Returns Change Primerica's (PRI) Narrative?

In the second quarter of 2026, Primerica, Inc. reported higher revenue of US$865.07 million and net income of US$202.28 million, alongside increased earnings per share versus a year earlier. At the same time, Primerica affirmed a US$1.20 per share dividend and completed US$270.01 million of share repurchases, underscoring its focus on returning capital to shareholders. We’ll now examine how Primerica’s stronger earnings and completed share repurchase program affect the company’s investment...
NYSE:EOG
NYSE:EOGOil and Gas

EOG Resources (EOG) Is Up 5.8% After Strong Q2 Earnings And Production Jump Has The Bull Case Changed?

EOG Resources reported past second-quarter 2026 results with revenue of US$8.62 billion and net income of US$2.72 billion, alongside sharply higher earnings per share versus a year earlier. The company’s strong quarter was underpinned by higher production across crude oil, natural gas liquids, and natural gas, complemented by ongoing buybacks and a regular US$1.02 per-share dividend. We’ll now explore how this jump in production volumes reshapes EOG Resources’ existing investment narrative...
NYSE:MSCI
NYSE:MSCICapital Markets

Buy The Dip Ideas Beyond ETFs With Morningstar Ameriprise And MSCI

Every major market slide feels uncomfortable, yet history often treats those periods as turning points for patient investors who stay the course. With fresh attention on how past S&P 500 drawdowns set the stage for long-term gains, broad U.S. equity index ETFs are back in focus. This article walks through 3 ETFs from our screener that sit at the heart of that story and explains how each is tied to today’s renewed interest in dip buying. The ETFs highlighted below are just a starting sample...
NasdaqGS:ICUI
NasdaqGS:ICUIMedical Equipment

Upgraded 2026 Earnings Guidance After Softer Q2 Might Change The Case For Investing In ICU Medical (ICUI)

ICU Medical, Inc. reported past second-quarter 2026 results showing sales of US$551.68 million versus US$548.87 million a year earlier, with net income falling to US$19.09 million from US$35.34 million and diluted EPS from continuing operations easing to US$0.76 from US$1.43. Despite softer quarterly earnings, the company’s six-month net income more than doubled year on year and management raised full-year 2026 GAAP net income guidance to US$73 million–US$83 million and GAAP diluted EPS...
NasdaqGS:PRDO
NasdaqGS:PRDOConsumer Services

Perdoceo Education (PRDO), Why Is It Getting Fresh Attention?

Perdoceo Education earnings and dividend move into focus Perdoceo Education (PRDO) is back on investors’ radar after reporting second quarter and first half 2026 results, lifting its quarterly dividend, and issuing fresh earnings guidance for the upcoming quarter and full year. See our latest analysis for Perdoceo Education. Against this backdrop, Perdoceo Education’s share price of $32.01 comes after a year-to-date share price return of 10.0%, while the 5-year total shareholder return of...
NYSE:EQH
NYSE:EQHDiversified Financial

Is Equitable’s Q2 Loss and US$2.81 Billion Buyback Altering The Investment Case For Equitable Holdings (EQH)?

In the second quarter of 2026, Equitable Holdings reported revenue of US$1,658 million, a net loss of US$453 million, and basic loss per share of US$1.68, while six‑month results showed higher revenue of US$5,888 million and net income of US$168 million. Over the same April–June period, Equitable Holdings repurchased US$366 million of its own shares, completing US$2.81 billion of buybacks since early 2024 and signaling ongoing focus on capital return alongside mixed quarterly...
NYSE:AIN
NYSE:AINMachinery

Is Albany International (AIN) Overvalued Following Q2 Earnings And Third Quarter Guidance?

Why Albany International’s latest earnings and guidance matter for investors Albany International (AIN) drew fresh attention after reporting second quarter 2026 results alongside new revenue guidance for the third quarter. The company also updated investors on progress under its existing share repurchase program. See our latest analysis for Albany International. Over the past year Albany International’s share price has shown mixed momentum, with a 1 day share price return of 1.22% and a 7 day...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

Is Dividend Debut and Earnings Strength Altering The Investment Case For Palomar Holdings (PLMR)?

Palomar Holdings, Inc. reported second-quarter 2026 results showing revenue of US$314.42 million and net income of US$52.59 million, and in July 2026 its board declared an initial quarterly cash dividend of US$0.45 per share, payable on September 2, 2026 to shareholders of record on August 19, 2026. The combination of higher revenue and earnings per share alongside the initiation of a regular dividend signals a shift toward returning cash to shareholders while highlighting the company’s...
NYSE:MMI
NYSE:MMIReal Estate

How Investors May Respond To Marcus & Millichap (MMI) Earnings Return, Dividend Reaffirmation And Buybacks

Marcus & Millichap, Inc. recently reported that second-quarter 2026 revenue rose to US$202.92 million and net income reached US$3.91 million, marking a shift back to profitability and was accompanied by continued share repurchases under its 2022 buyback program. Alongside this earnings recovery, the company affirmed a regular US$0.25 per-share dividend and emphasized diversification into leasing and appraisal services, highlighting a focus on broadening revenue sources while returning cash...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

Is TransMedics Group (TMDX) Fairly Valued As Revenue Grew And 2026 Guidance Was Raised?

TransMedics Group (TMDX) is back in focus after reporting second quarter 2026 results that combined higher revenue with lower net income, along with a raised lower end for full year revenue guidance. See our latest analysis for TransMedics Group. The mixed second quarter numbers and higher revenue guidance have arrived after a volatile spell for TransMedics Group, with a 19.74% 30 day share price return and a 29.62% 90 day share price return contrasting with a year to date share price return...
NasdaqGS:POWI
NasdaqGS:POWISemiconductor

The Bull Case For Power Integrations (POWI) Could Change Following 2,200 V PowiGaN Breakthrough And ESOP Shelf Registration

Power Integrations recently reported second-quarter 2026 results showing higher sales of US$118.94 million and net income of US$9.83 million, affirmed its US$0.215 per-share dividend for September 30, 2026, issued third-quarter revenue guidance of US$122 million to US$130 million, and filed a US$123.9 million shelf registration for 2,000,000 common shares tied to an ESOP offering. At the same time, the company announced its PowiGaN GaN technology is now rated up to 2,200 V, extending its...
NasdaqGM:WLDN
NasdaqGM:WLDNProfessional Services

Stronger Q2 2026 Results And Higher Revenue Targets Could Be A Game Changer For Willdan Group (WLDN)

Willdan Group, Inc. reported past second-quarter 2026 results showing sales of US$231.03 million and net income of US$24.35 million, with both basic and diluted earnings per share from continuing operations higher than a year earlier. Alongside these stronger results, Willdan set 2026 net revenue targets of US$415 million to US$430 million, highlighting management’s confidence backed by new contract wins and recent acquisition integration. With Willdan’s updated 2026 net revenue targets now...
NasdaqGM:XNCR
NasdaqGM:XNCRBiotechs

Do Xencor’s (XNCR) Mixed 2026 Loss Trends Hint at Shifting Cost Discipline?

Xencor, Inc. reported past second-quarter 2026 results showing a reduced net loss of US$21.73 million, or US$0.29 per share, while its net loss for the first half of 2026 widened to US$150.65 million, or US$1.99 per share. This contrast between an improving quarterly loss and a much larger year-to-date loss highlights the company’s uneven cost profile and execution so far in 2026. We’ll now examine how the narrower quarterly loss but much larger year-to-date loss could influence Xencor’s...
NYSE:BRX
NYSE:BRXRetail REITs

What Is Drawing Attention To Brixmor Property Group (BRX)?

Insider sale and new leases put Brixmor in focus A recent insider sale has put Brixmor Property Group (BRX) on investors’ radar again. Director Michael B. Berman sold 9,000 shares on August 12, while the company highlighted record new leasing commitments. See our latest analysis for Brixmor Property Group. At around US$29.98, Brixmor Property Group’s 1 month share price return is down 7.95%, even though its year to date share price return is up 15.49% and the 5 year total shareholder return...
NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer Stock And 2 AI Healthcare Picks Built Around Productivity Growth

With global bond yields high and borrowing costs less forgiving, capital is flowing toward companies that can raise productivity rather than just cut expenses. Transformative AI healthcare stocks sit right in that sweet spot. They use data and algorithms to help doctors work faster and more accurately, which can appeal when every dollar needs to work harder. This article highlights three AI healthcare stocks from our screener to watch closely. The three stocks below are just a sample from...
NasdaqGM:XENE
NasdaqGM:XENEBiotechs

Xenon Pharmaceuticals (XENE) Could Be 23% Undervalued As Epilepsy Growth Narrative Holds

Xenon Pharmaceuticals (NasdaqGM:XENE) is back in focus after reporting a second quarter net loss of US$110.74 million and preparing to present at Stifel’s 2026 Biotech Summer Summit on August 10 in Newport. See our latest analysis for Xenon Pharmaceuticals. Despite the wider loss, Xenon Pharmaceuticals shares have cooled in the last month with a 1-month share price return of down 8.66% and a 7-day move of down 1.59%. However, the 90-day share price return of 16.09% and 1-year total...
NYSE:BW
NYSE:BWElectrical

Is Babcock & Wilcox Enterprises (BW) Undervalued As Siemens Data Center Deals Lift Guidance?

Babcock & Wilcox Enterprises (BW) is back in focus after agreeing with Siemens Energy to start work on 20 steam turbine generator sets for data center projects, alongside higher financial guidance and a sizeable project pipeline. See our latest analysis for Babcock & Wilcox Enterprises. Those Siemens Energy turbines and the stronger guidance seem to be feeding into the price action. Babcock & Wilcox Enterprises now trades at US$10.29, with a 1 day share price return of 10.05% and a year to...
NYSE:KIM
NYSE:KIMRetail REITs

What Is Drawing Attention To Kimco Realty (KIM) Today?

Kimco Realty (KIM) drew fresh attention after raising its full year 2026 net income guidance and lifting its quarterly dividend by 12%. These updates highlighted management’s current outlook and cash returns to shareholders. See our latest analysis for Kimco Realty. At a share price of $24.41, Kimco Realty has combined a 21.68% year to date share price return with a 20.49% total shareholder return over the past year. This points to momentum that has remained broadly supportive through recent...
NasdaqGM:QMCO
NasdaqGM:QMCOTech

Quantum (QMCO) Is Up 116.9% After Stronger Revenue, Record Backlog And Upbeat Q2 Guidance - What's Changed

In the first quarter ended June 30, 2026, Quantum Corporation reported revenue of US$80.8 million, up from US$64.29 million a year earlier, alongside a net loss of US$155.29 million and a basic loss per share from continuing operations of US$7.06. Despite the wider loss, Quantum issued fiscal second-quarter 2027 revenue guidance of about US$82.0 million and pointed to a record backlog, a cleaner balance sheet, and easing supply constraints that analysts say are reshaping expectations for...